Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Remedi is stocked at 247 licensed dispensaries across Illinois, Pennsylvania, and 3 other states, 131 of them in Illinois, with the deepest coverage in Chicago, Champaign, East Peoria, Joliet, and Quincy. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Remedi concentrated 88.56% of sales in Concentrates, where sales grew 18.08% year over year and 7.25% month over month, while the smaller Tincture & Sublingual segment at 9.68% share declined 36.99% YoY and 3.60% MoM. Capsules fell further to 1.76% share with YoY down 63.53% and MoM down 42.03%, alongside a brand-average price that decreased 5.46% YoY to one disclosed average price point of $21.82. With Concentrates holding rank 19 in Illinois and gaining share while peripheral formats contract, the pattern implies deliberate consolidation around a single category where momentum offsets shrinkage elsewhere.
The category tilt raises positioning stakes: a higher-weight Concentrates mix with 7.25% MoM growth against a 3.60% MoM decline in Tincture & Sublingual and a 42.03% MoM drop in Capsules indicates reliance on a growth engine that may be sensitive to rank shifts around position 19. Coupled with an 18.08% YoY lift in Concentrates versus a 36.99% YoY decline in Tincture & Sublingual and a 63.53% YoY decline in Capsules, the lower average price of 5.46% YoY suggests price-led competitiveness in the core while deprioritizing smaller formats, implying a need to defend Concentrates share to sustain overall August 2026 brand growth as diversification headwinds persist.
Competitive Landscape
Remedi is ranked #19 in IL Concentrates in August 2026, improving 5 positions year over year from #24 and rising 3 spots since May 2026 from #22, while also marking a peak rank of #19 in August 2026; by contrast, Aeriz held steady at #1 both year over year and in August 2026, and IC Collective climbed from #5 to #3 year over year, signaling that Remedi’s upward but slower rank movement is occurring in a tier where top competitors are consolidating higher positions, implying that Remedi’s current trajectory points to incremental gains without immediate entry into the top-10 unless pace accelerates.

Notable Products
Banana Cream x Jealousy RSO Syringe (1g) posted the steepest pullback in August 2026 with a -22.4% MoM change at rank 8, while CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) fell -13.4% at rank 7, signaling demand is consolidating away from certain 1g and balanced-tincture formats. At the top, Indica Rest RSO Syringe (0.5g) rose +15.0% and held rank 1, and Orange Chem RSO Syringe (1g) jumped +42.0% at rank 9, indicating potency-led RSO variants are absorbing share even as some SKUs retreat. Four of the top ten are RSO Concentrates, with Hybrid Relief RSO Syringe (0.5g) up +38.6% at rank 4 and Indica Relief RSO Syringe (0.5g) edging down -2.4% at rank 2, implying the 0.5g RSO format anchors the franchise while flavor-led 1g entries create volatility at the lower ranks. The product mix points toward deeper commitment to RSO-led pain and rest solutions, with selective pruning of underperforming 1g and balanced-tincture lines to reinforce the highest-velocity 0.5g syringes and sustain rank 1-4 density.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







